Caval Valve Implantation: First of Its Kind in a Rare Environment
Overview
Overview
Authors
Affiliations
Affiliations
Soon will be listed here.
Abstract
Transcatheter caval valve implantation (CAVI) is an emerging treatment option for inoperable patients with severe tricuspid regurgitation (TR). We present a case of a 76-year-old lady with severe TR and recurrent right heart failure who improved after CAVI. This is the first such case in a rare environment.
Citing Articles
Coelho B, Banoub M, Mooney J, Anastasius M, Doost A, Asrress K CASE (Phila). 2025; 9(2):40-51.
PMID: 40027931 PMC: 11865814. DOI: 10.1016/j.case.2024.12.002.
References
1.
Baumgartner H, Falk V, Bax J, De Bonis M, Hamm C, Holm P
. 2017 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J. 2017; 38(36):2739-2791.
DOI: 10.1093/eurheartj/ehx391.
View
2.
Badano L, Muraru D, Enriquez-Sarano M
. Assessment of functional tricuspid regurgitation. Eur Heart J. 2013; 34(25):1875-85.
DOI: 10.1093/eurheartj/ehs474.
View
3.
ONeill B, Wang D, Pantelic M, Song T, Guerrero M, Greenbaum A
. Transcatheter caval valve implantation using multimodality imaging: roles of TEE, CT, and 3D printing. JACC Cardiovasc Imaging. 2015; 8(2):221-5.
DOI: 10.1016/j.jcmg.2014.12.006.
View
4.
Rodes-Cabau J, Hahn R, Latib A, Laule M, Lauten A, Maisano F
. Transcatheter Therapies for Treating Tricuspid Regurgitation. J Am Coll Cardiol. 2016; 67(15):1829-1845.
DOI: 10.1016/j.jacc.2016.01.063.
View
5.
Lauten A, Figulla H, Unbehaun A, Fam N, Schofer J, Doenst T
. Interventional Treatment of Severe Tricuspid Regurgitation: Early Clinical Experience in a Multicenter, Observational, First-in-Man Study. Circ Cardiovasc Interv. 2018; 11(2):e006061.
DOI: 10.1161/CIRCINTERVENTIONS.117.006061.
View